Hypofractionated Radiotherapy With Concomitant Tumor Bed Boost for Breast Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age20-85
SponsorNational Taiwan University Hospital
About this trial
Hypofractionated breast radiotherapy with concomitant tumor bed boost for early breast cancer or ductal breast carcinoma in situ after partial mastectomy
Eligibility criteria
Qualifiers
Female patients with histologically confirmed early-stage breast cancer (T1-2 and N0-1) or ductal carcinoma in situ (DCIS).
Patients undergoing breast-conserving surgery
Age ≥ 20 years
Karnofsky Performance Status (KPS) ≥70%
Disqualifiers
Pregnant patients
Patients requiring re-irradiation of the thoracic region
Trial design
Treatments tested in this trial
- Hypofractionated Radiation Therapy
Treatment groups
315 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov